FIRM FIXED PRICENO SET ASIDE USED.
ASTRAZENECA PHARMACEUTICALS LP - 2 LINE ITEMS FOR ANTI-INTERLEUKIN MONOCLONAL ANTIBODIES FOR ASTHMA (BENRALIZUMAB). AWARDED FOR A BASE YEAR OF 2/15/2021 TO 2/14/2022 PLUS FOUR ONE-YEAR OPTION PERIODS.
PIID: 36E79721D0007Solicitation ID: 36E79720R0068
Signed Date: Jan 20, 2026Effective Date: Feb 15, 2021
Vendor
ASTRAZENECA PHARMACEUTICALS LP
NAICS
325412
Signed Date
Jan 20, 2026
Key Details
Description
2 LINE ITEMS FOR ANTI-INTERLEUKIN MONOCLONAL ANTIBODIES FOR ASTHMA (BENRALIZUMAB). AWARDED FOR A BASE YEAR OF 2/15/2021 TO 2/14/2022 PLUS FOUR ONE-YEAR OPTION PERIODS.
Context & Analysis
On Jan 20, 2026, Department of Veterans Affairs to ASTRAZENECA PHARMACEUTICALS LP for 2 line items for anti-interleukin monoclonal antibodies for asthma (benralizumab). awarded for a base year of 2/15/2021 to 2/14/2022 plus four one-year option periods.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.